Effects of hydrocortisone on microcirculatory alterations in patients with septic shock

Critical Care Medicine

Volumn 37, Issue 4, 2009, Pages 1341-1347

  Büchele, Gustavo Luiz ^a   Silva, Eliézer ^b   Ospina Tascón, Gustavo Adolfo ^a   Vincent, Jean Louis ^a   De Backer, Daniel ^a  

^a ERASME HOSPITAL   (Belgium)

^b HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

Intensive care; Microcirculation; Orthogonal polarization spectral imaging; Regional blood flow; Septic shock; Steroids

Indexed keywords

HYDROCORTISONE;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; CAPILLARY FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN TEST; DRUG EFFECT; FEMALE; HEMODYNAMICS; HUMAN; INTENSIVE CARE UNIT; MALE; MICROCIRCULATION; PRIORITY JOURNAL; SEPTIC SHOCK; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; FEMALE; HUMANS; HYDROCORTISONE; MALE; MICROCIRCULATION; MIDDLE AGED; SHOCK, SEPTIC;

EID: 67650501164     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181986647     Document Type: Article

References (48)

1. Silva E, Pedro Mde A, Sogayar AC, et al: Brazilian Sepsis Epidemiological Study (BASES study). Crit Care 2004; 8:R251-R260
2. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310
3. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002; 166:98-104
4. Tsai AG, Cabrales P, Winslow RM, et al: Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia. Am J Physiol Heart Circ Physiol 2003; 285:H1537-H1545
5. Groner W, Winkelman JW, Harris AG, et al: Orthogonal polarization spectral imaging: A new method for study of the microcircula-tion. Nat Med 1999; 5:1209-1212
6. Spronk PE, Ince C, Gardien MJ, et al: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002; 360: 1395-1396
7. Trzeciak S, Dellinger RP, Parrillo JE, et al: Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007; 49:88-98
8. De Backer D, Creteur J, Dubois MJ, et al: The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34:403-408
9. De Backer D, Verdant C, Chierego M, et al: Effects of drotecogin alfa activated on micro-circulatory alterations in patients with severe sepsis. Crit Care Med 2006; 34:1918-1924
10. Sakr Y, Chierego M, Piagnerelli M, et al: Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med 2007; 35:1639-1644
11. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
12. Dellinger RP, Carlet JM, Masur H, et al: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004; 30:536-555
13. Sprung CL, Annane D, Keh D, et al: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
14. Annane D, Sebille V, Troche G, et al: A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283:1038-1045
15. Prigent H, Maxime V, Annane D: Science review: Mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care 2004; 8:243-252
16. Lipiner-Friedman D, Sprung CL, Laterre PF, et al: Adrenal function in sepsis: The retrospective Corticus cohort study. Crit Care Med 2007; 35:1012-1018
17. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdy-namic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
18. Siraux V, De Backer D, Yalavatti G, et al: Relative adrenal insufficiency in patients with septic shock: Comparison of low-dose and conventional corticotropin tests. Crit Care Med 2005; 33:2479-2486
19. Bollaert PE, Charpentier C, Levy B, et al: Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26:645-650
20. Annane D, Bellissant E, Sebille V, et al: Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve. Br J Clin Pharmacol 1998; 46:589-597
21. Gorne RC, Greif C, Metzner U, et al: Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers. Skin Pharmacol Physiol 2007; 20: 133-140
22. Boerma EC, Kuiper MA, Kingma WP, et al: Disparity between skin perfusion and sublingual microcirculatory alterations in severe sepsis and septic shock: A prospective observational study. Intensive Care Med 2008; 34: 1294-1298
23. Levy MM, Fink MP, Marshall JC, et al: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31:1250-1256
24. Knaus WA, Draper EA, Wagner DP, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
25. Vincent JL, Moreno J, Takala J, et al: The SOFA (Sepsis-Related Organ Failure Assessment) score to describe organ dysfunction/ failure. Intensive Care Med 2000; 22:707-710
26. De Backer D, Hollenberg S, Boerma C, et al: How to evaluate the microcirculation: Report of a round table conference. Crit Care 2007; 11:R101
27. Bellissant E, Annane D: Effect of hydrocorti-sone on phenylephrine - mean arterial pressure dose-response relationship in septic shock. Clin Pharmacol Ther 2000; 68: 293-303
28. Saito T, Fuse A, Gallagher ET, et al: The effect of methylprednisolone on myocardial beta-adrenergic receptors and cardiovascular function in shock patients. Shock 1996; 5:241-246
29. Morel J, Venet C, Donati Y, et al: Adrenal axis function does not appear to be associated with hemodynamic improvement in septic shock patients systematically receiving glucocorticoid therapy. Intensive Care Med 2006; 32:1184-1190
30. Nakajima Y, Baudry N, Duranteau J, et al: Effects of vasopressin, norepinephrine and L-arginine on intestinal microcirculation in endotoxemia. Crit Care Med 2006; 34: 1752-1757
31. Bhagat K, Vallance P: Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 1997; 96:3042-3047
32. Cronstein BN, Kimmel SC, Levin RI, et al: A mechanism for the antiinflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1992; 89:9991-9995
33. Tailor A, Tomlinson A, Salas A, et al: Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: Role of intercellular adhesion molecule 1 and KC. Gut 1999; 45:705-712
34. Vachharajani V, Vital S, Russell J, et al: Glucocorticoids inhibit the cerebral microvascu-lar dysfunction associated with sepsis in obese mice. Microcirculation 2006; 13: 477-487
35. Zhang XW, Thorlacius H: Dexamethasone inhibits arteriolar leukocyte rolling and adhesion induced by tumor necrosis factor-alpha in vivo. Inflamm Res 2000; 49:95-97
36. Filep JG, Delalandre A, Payette Y, et al: Glucocorticoid receptor regulates expression of L-selectin and CD11/CD18 on human neutrophils. Circulation 1997; 96:295-301
37. Davenpeck KL, Zagorski J, Schleimer RP, et al: Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: Regulation by glucocorticoids and role of cytokines. J Immunol 1998; 161:6861-6870
38. Radomski MW, Palmer RMJ, Moncada S: Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990; 87: 10043-10047
39. Hafezi-Moghadam A, Simoncini T, Yang Z, et al: Acute cardiovascular protective effects of corticosteroids are mediated by non-tran-scriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8:473-479
40. Kubes P, Suzuki M, Granger DN: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991; 88: 4651-4655
41. Lindemann S, Sharafi M, Spiecker M, et al: NO reduces PMN adhesion to human vascular endothelial cells due to downregulation of ICAM-1 mRNA and surface expression. Thromb Res 2000; 97:113-123
42. Pitzalis C, Pipitone N, Perretti M: Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann N Y Acad Sci 2002; 966: 108-118
43. Kirveskari J, Helinto M, Moilanen JA, et al: Hydrocortisone reduced in vivo, inflammation-induced slow rolling of leukocytes and their extravasation into human conjunctiva. Blood 2002; 100:2203-2207
44. Aboab J, Polito A, Orlikowski D, et al: Hydrocortisone effects on cardiovascular variability in septic shock: A spectral analysis approach. Crit Care Med 2008; 36:1481-1486
45. Creteur J, De Backer D, Sakr Y, et al: Sublingual capnometry tracks microcirculatory changes in septic patients. Intensive Care Med 2006; 32:516-523
46. Wiik A, Ekman M, Morgan G, et al: Oestrogen receptor beta is present in both muscle fibres and endothelial cells within human skeletal muscle tissue. Histochem Cell Biol 2005; 124:161-165
47. Prorock AJ, Hafezi-Moghadam A, Laubach VE, et al: Vascular protection by estrogen in ischemia-reperfusion injury requires endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 2003; 284: H133-H140
48. Dellinger RP, Levy MM, Carlet JM, et al: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327